Code	Sector	Market
653A	Pharmaceuticals	Growth

Date of listing approval	2026/09/28
Expected Date	2026/11/02
Lead Underwriter	Tokai Tokyo Securities Co., Ltd
Description

Listed Shares(total)	1,987,900
Trading Unit	100
New Shares	940,700
Existing Shares	1,047,200
Shares Outstanding	PreIPO 7,114,000.00
	PostIPO 8,054,700.00
Paid Up Capital	PreIPO Y90,000,000
	PostIPO
Expected Pricing Date	2026/10/13
Book Building Start	2026/10/15
Book Building End	2026/10/21
Fix Date	2026/10/22
Offering Starts	2026/10/23
Offering Ends	2026/10/28
Expect Pricing	-
Notional PER (based on previous period)	-
Offering Price
Offering Price PER (based on previous period)	-
Offering Price PBR (based on previous period)
Use of Funds Raised

Units:Y1,000

Fiscal Year End:2024/03
	Consolidated	Non-consolidated
Revenue	-	66,161
Current Profit	-	-147,911
Net Profit	-	-148,215
Net Assets	-	165,888

Fiscal Year End:2025/03
	Consolidated	Non-consolidated
Revenue	-	144,459
Current Profit	-	-103,525
Net Profit	-	-103,830
Net Assets	-	532,058

Fiscal Year End:2026/03
	Consolidated	Non-consolidated
Revenue	-	337,548
Current Profit	-	36,436
Net Profit	-	36,131
Net Assets	-	568,190

Recent Quarter 2026/06
	Consolidated	Non-consolidated
Revenue	-	41,857
Current Profit	-	-36,894
Net Profit	-	-36,970
Net Assets	-	531,219

Per Share Units:Y1

Fiscal Year End:2024/03
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-24.96	-111.20

Fiscal Year End:2025/03
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-16.60	-138.42

Fiscal Year End:2026/03
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	5.08	-128.95

Fiscal Year End:Recent Quarter 2026/06
	Consolidated	Non-consolidated
Dividend
Net Earning	-	-5.20
Equity	-	-

■Over allotment (298,000)

Name	Address

Allocation	Underwriter	Tel
0%	Nomura	03-3211-1811
0%	Tokai Tokyo Securities Co., Ltd	03-3566-8811
0%	SBI SECURITIES Co.,Ltd.	03-5562-7210
0%	Marusan Securities Co., Ltd	03-3272-5211
0%	Monex, Inc	03-4323-3800